Cargando…
Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease
BACKGROUND AND AIMS: Histological scoring plays a key role in the assessment of disease activity in ulcerative colitis [UC] and is also important in Crohn´s disease [CD]. Currently, there is no common scoring available for UC and CD. We aimed to validate the Inflammatory Bowel Disease [IBD]—Distribu...
Autores principales: | Lang-Schwarz, Corinna, Angeloni, Miriam, Agaimy, Abbas, Atreya, Raja, Becker, Christoph, Dregelies, Theresa, Danese, Silvio, Fléjou, Jean-François, Gaßler, Nikolaus, Grabsch, Heike I, Hartmann, Arndt, Kamarádová, Kateřina, Kühl, Anja A, Lauwers, Gregory Y, Lugli, Alessandro, Nagtegaal, Iris, Neurath, Markus F, Oberhuber, Georg, Peyrin-Biroulet, Laurent, Rath, Timo, Riddell, Robert, Rubio, Carlos A, Sheahan, Kieran, Siegmund, Britta, Tilg, Herbert, Villanacci, Vincenzo, Westerhoff, Maria, Ferrazzi, Fulvia, Vieth, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495487/ https://www.ncbi.nlm.nih.gov/pubmed/33773497 http://dx.doi.org/10.1093/ecco-jcc/jjab055 |
Ejemplares similares
-
Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn’s disease
por: Lang-Schwarz, Corinna, et al.
Publicado: (2020) -
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
por: Rath, Timo, et al.
Publicado: (2018) -
Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey
por: Nardone, Olga Maria, et al.
Publicado: (2023) -
Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise
por: Danese, Silvio, et al.
Publicado: (2021) -
Evolution of IL-23 Blockade in Inflammatory Bowel Disease
por: Danese, Silvio, et al.
Publicado: (2022)